Sub-10¢ Watch: 10 Stocks That Could Explode — October 10, 2026

Introduction In the world of penny stocks, opportunities for explosive growth often come with substantial risk. As of October 2026, several stocks are trading under $0.10 that have garnered attention due to their unique catalysts and market conditions. Here’s a selection of ten stocks that could potentially soar in the coming months.

1. SNDL - Sundial Growers Inc. - **Current Price**: $0.04 - **Sector**: Cannabis - **Volume Profile**: Increasing volume suggests accumulation as investors anticipate regulatory changes in the cannabis sector. - **Short Interest**: Approximately 15% of the float is shorted, indicating a potential squeeze. - **Catalyst**: Potential legalization of cannabis in several U.S. states could drive significant sales growth. - **Technical Setup**: The stock is bouncing off a support level of $0.035, indicating bullish momentum. - **Risk Factors**: Market volatility and regulatory hurdles could impede growth. - **Bull Case Price Target**: $0.08 in the next 60 days. - **Risk Rating**: 🟡 High

2. MVIS - MicroVision, Inc. - **Current Price**: $0.09 - **Sector**: Technology - **Volume Profile**: Volume has been steadily increasing, hinting at accumulation as investors await product launches. - **Short Interest**: High short interest at 20%, making it a prime candidate for a short squeeze. - **Catalyst**: Upcoming launch of a new LiDAR product could significantly impact revenue. - **Technical Setup**: The stock is breaking out of a consolidation phase above $0.08. - **Risk Factors**: Product delays or failure to meet performance expectations could negatively affect stock price. - **Bull Case Price Target**: $0.12 within 75 days. - **Risk Rating**: 🟡 High

3. CLOV - Clover Health Investments Corp. - **Current Price**: $0.05 - **Sector**: Health Care - **Volume Profile**: Increasing volume indicates growing interest, particularly among retail investors. - **Short Interest**: Approximately 18% shorted, suggesting a potential short squeeze. - **Catalyst**: Possible FDA approval for a new health technology product could drive stock price higher. - **Technical Setup**: Currently bouncing off a support level of $0.045. - **Risk Factors**: Regulatory setbacks or earnings misses could lead to further declines. - **Bull Case Price Target**: $0.09 in the next 30 days. - **Risk Rating**: 🟡 High

4. HCMC - Healthier Choices Management Corp. - **Current Price**: $0.006 - **Sector**: Consumer Goods - **Volume Profile**: Significant volume spikes indicate accumulation as the company expands its product line. - **Short Interest**: Low short interest, less than 5%, indicating fewer risks associated with short squeezes. - **Catalyst**: Potential patent approval for a new product could act as a significant catalyst. - **Technical Setup**: The stock is testing resistance at $0.007. - **Risk Factors**: Market competition and product acceptance could hinder growth. - **Bull Case Price Target**: $0.015 in 90 days. - **Risk Rating**: 🟢 Moderate

5. GERN - Geron Corporation - **Current Price**: $0.08 - **Sector**: Biotechnology - **Volume Profile**: Increasing volume trends suggest accumulation ahead of clinical trial results. - **Short Interest**: 25% short interest indicates potential for a squeeze if trial results are favorable. - **Catalyst**: Upcoming clinical trial results could significantly impact stock price. - **Technical Setup**: Stock is at a critical support level of $0.075. - **Risk Factors**: Negative trial results could lead to significant losses. - **Bull Case Price Target**: $0.12 in the next 60 days. - **Risk Rating**: 🟡 High

6. AITX - Artificial Intelligence Technology Solutions, Inc. - **Current Price**: $0.02 - **Sector**: Technology - **Volume Profile**: Rising volume suggests growing enthusiasm following recent product announcements. - **Short Interest**: Very low, under 2%, reducing risk of a short squeeze. - **Catalyst**: Expansion into new markets and potential partnerships could drive growth. - **Technical Setup**: Recently broke out from a long consolidation phase. - **Risk Factors**: Market acceptance of its products and competition from larger tech firms. - **Bull Case Price Target**: $0.04 in 90 days. - **Risk Rating**: 🟢 Moderate

7. ZOM - Zomedica Corp. - **Current Price**: $0.10 - **Sector**: Health Care - **Volume Profile**: Volume has been increasing, signaling potential accumulation ahead of product launches. - **Short Interest**: Approximately 22% short interest, indicating a potential for a squeeze. - **Catalyst**: Launching a new veterinary diagnostic product could significantly boost revenues. - **Technical Setup**: Stock is testing resistance at $0.10, breaking above could indicate bullish momentum. - **Risk Factors**: Failure to meet sales expectations could lead to price drops. - **Bull Case Price Target**: $0.15 within 60 days. - **Risk Rating**: 🟡 High

8. ENZ - Enzo Biochem, Inc. - **Current Price**: $0.09 - **Sector**: Health Care - **Volume Profile**: Increasing volume indicates a growing interest from investors. - **Short Interest**: High at 30%, creating a squeeze potential if positive news arises. - **Catalyst**: Positive earnings report could trigger a rally. - **Technical Setup**: Recently bounced off a support level of $0.08. - **Risk Factors**: Earnings disappointments could lead to further declines. - **Bull Case Price Target**: $0.12 in the next 30 days. - **Risk Rating**: 🟡 High

9. AABB - Asia Broadband Inc. - **Current Price**: $0.07 - **Sector**: Mining - **Volume Profile**: Increasing volume indicates accumulation as investor interest grows. - **Short Interest**: Low, below 5%, indicating limited downside from short selling. - **Catalyst**: Rising gold prices and increased production could drive stock higher. - **Technical Setup**: Recently broke out from a consolidation phase. - **Risk Factors**: Commodity price volatility could significantly impact revenues. - **Bull Case Price Target**: $0.10 in 60 days. - **Risk Rating**: 🟢 Moderate

10. LUXH - LuxUrban Hotels Inc. - **Current Price**: $0.04 - **Sector**: Hospitality - **Volume Profile**: Rising volume suggests accumulation as the company expands its portfolio. - **Short Interest**: Low short interest, under 5%, indicating less risk of a squeeze. - **Catalyst**: Recovery in the hospitality sector post-pandemic could drive growth. - **Technical Setup**: The stock is testing support at $0.035. - **Risk Factors**: Ongoing economic uncertainties could affect recovery. - **Bull Case Price Target**: $0.06 in 90 days. - **Risk Rating**: 🟢 Moderate

Why These Price Ranges Matter Low-float, low-price stocks present unique mechanical advantages. Their lower market caps mean that even small buying interest can lead to significant price movements. Additionally, these stocks often have less liquidity, increasing volatility and the potential for rapid gains—or losses. Investors should remain cautious, as the same factors that can lead to explosive gains can also lead to steep declines.

How to Trade Them Safely Position sizing is critical when trading penny stocks. Investors should consider using limit orders to control entry prices, especially in volatile markets. Timing catalysts—such as earnings reports or product launches—can enhance the likelihood of favorable outcomes. Always set stop-loss orders to manage risk effectively and remain disciplined in trading.

Catalyst Calendar - **SNDL**: Regulatory updates expected in Q4 2026. - **MVIS**: Product launch scheduled for late November 2026. - **CLOV**: FDA decision expected in December 2026. - **GERN**: Clinical trial results due in January 2027.

Educational content only. Not financial advice. DYOR.